Bank Pictet & Cie (Asia)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-10,203
Closed -$997K 65
2017
Q1
$997K Sell
10,203
-1,362
-12% -$130K 0.45% 36
2016
Q4
$1.02M Hold
11,565
0.52% 32
2016
Q3
$1.12M Hold
11,565
0.65% 30
2016
Q2
$992K Sell
11,565
-240
-2% -$21.5K 0.63% 31
2016
Q1
$1.03M Sell
11,805
-2,325
-16% -$208K 0.61% 32
2015
Q4
$1.59M Buy
+14,130
New +$1.53M 0.92% 31

Other funds holding IBB

Bank Pictet & Cie (Asia)'s IBB Position: Q2 2017 in Review

Bank Pictet & Cie (Asia) sold out of iShares Biotechnology ETF (IBB) in Q2 2017, closing a stake of 10,203 shares — an estimated $997K sold.

Bank Pictet & Cie (Asia) first reported a position in IBB in Q4 2015 and held it in 6 quarters. The position peaked at $1.59M in Q4 2015. 562 funds tracked by Wall St. Rank hold IBB as of Q2 2017.

  • Bank Pictet & Cie (Asia) reported no remaining iShares Biotechnology ETF position as of Q2 2017 after selling out during the quarter.
  • Bank Pictet & Cie (Asia) sold 10,203 iShares Biotechnology ETF shares in Q2 2017, an estimated $997K.
  • Bank Pictet & Cie (Asia) first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 6 quarters.
  • Bank Pictet & Cie (Asia)'s iShares Biotechnology ETF position peaked at $1.59M in Q4 2015.
  • 562 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2017.

Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2017, filed 9 Aug 2017.